Asthma Exacerbation Management in Children

Appropriate Management of Asthma Exacerbations

The American Academy of Allergy, Asthma, and Immunology recommends that short-acting beta2-agonists (SABAs) like albuterol are the treatment of choice for relief of acute asthma symptoms and exacerbations in children above 6 years 2
For children 5-11 years with exacerbations, albuterol MDI should be given as 4-8 puffs every 20 minutes for 3 doses, then every 1-4 hours as needed, as suggested by the American Academy of Pediatrics 3
Increasing use of SABA treatment or using SABA >2 days a week for symptom relief generally indicates inadequate asthma control and the need for initiating or intensifying anti-inflammatory therapy, according to the National Asthma Education and Prevention Program 2

The Global Initiative for Asthma suggests that budesonide/formoterol contains a long-acting beta2-agonist (formoterol) and an inhaled corticosteroid (budesonide), which are primarily intended for maintenance therapy in moderate or severe persistent asthma 2
Long-acting beta2-agonists (LABAs) like formoterol are not to be used as monotherapy for acute symptom relief during exacerbations, as recommended by the American College of Allergy, Asthma, and Immunology 2

For moderate to severe exacerbations in children, the recommended approach is to use SABA (albuterol) via MDI with spacer: 4-8 puffs every 20 minutes for 3 doses, then every 1-4 hours as needed, as suggested by the American Academy of Allergy, Asthma, and Immunology 3
For severe exacerbations, consider systemic corticosteroids (1-2 mg/kg/day of prednisone or equivalent, maximum 60 mg/day) for 3-10 days, as recommended by the National Asthma Education and Prevention Program 3

Monitor response to therapy closely, especially in young children, as suggested by the American Academy of Pediatrics 4
If a clear beneficial response is not observed within 4-6 weeks of initiating controller therapy, treatment should be reassessed, according to the Global Initiative for Asthma 4

Using combination ICS/LABA products (like Foracort) as rescue medication instead of SABAs during exacerbations is not recommended, as stated by the American College of Allergy, Asthma, and Immunology 2
Ensure proper education on medication use, inhaler technique, and written action plan for exacerbations, as recommended by the National Asthma Education and Prevention Program 6